Literature DB >> 34213339

Computational Methods Elucidate Consequences of Mutations and Post-translational Modifications on Troponin I Effective Concentration to Troponin C.

Austin M Cool1, Steffen Lindert1.   

Abstract

Ca2+ binding to cardiac troponin C (cTnC) causes a conformational shift that exposes a hydrophobic patch (cTnCHP) for binding of the cTnI switch peptide (cTnISP), ultimately resulting in contraction of the heart. The inhibitory peptide (cTnIIP), attached at the N-terminal end of the cTnISP, serves as a tether for the cTnISP to the rest of the troponin complex. Due to this tethered nature, the cTnISP remains within proximity of the hydrophobic patch region, resulting in the cTnCHP experiencing an elevated "effective concentration" of the cTnISP. Mutations to the cTnIIP region have been hypothesized to cause disease by affecting the ability of the cTnISP to "find" the hydrophobic patch, resulting in alterations to the heart's ability to contract normally. We tested this hypothesis using molecular dynamics (MD) simulations of the troponin complex using a model that contained all three subunits of troponin: C, I, and T. We developed methods that allowed us to quantitatively measure the effective concentration of the cTnISP from the simulations. A significant reduction in the cTnISP effective concentration was observed when the cTnIIP was removed from the system, showcasing the importance of a tethered cTnISP. Through accelerated MD methods, we proposed the minimum effective concentration of a tethered cTnISP to be approximately 21 mM. Modification of the cTnIIP via PKC-mediated phosphorylation of T143 was shown to significantly increase the estimated effective concentration of cTnISP, help the cTnISP find the cTnCHP more effectively, and maintain the relative shape of the cTnIIP when compared to the native model. All of these data indicate that pT143 may be able to help promote binding of cTnISP to the cTnCHP. We then tested six mutations within the cTnIIP region that are known cTnC Ca2+-sensitizing mutations and have been linked with cardiomyopathy. We did not observe a significant reduction in the effective concentration upon the introduction of these mutations; however, we did observe increased variability in the flexibility and dynamics of the cTnIIP region when compared to native. Our observations led us to hypothesize that the mechanism by which these cardiomyopathic mutations affect Ca2+ sensitivity is by altering the off rate of cTnISP from the hydrophobic patch.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34213339      PMCID: PMC8341295          DOI: 10.1021/acs.jpcb.1c03844

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   3.466


  40 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Mechanism of Cardiac Troponin C Calcium Sensitivity Modulation by Small Molecules Illuminated by Umbrella Sampling Simulations.

Authors:  Jacob D Bowman; William H Coldren; Steffen Lindert
Journal:  J Chem Inf Model       Date:  2019-05-29       Impact factor: 4.956

3.  Drastic Ca2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy.

Authors:  Fumiaki Yumoto; Qun-Wei Lu; Sachio Morimoto; Hiroyuki Tanaka; Naoko Kono; Koji Nagata; Takao Ojima; Fumi Takahashi-Yanaga; Yoshikazu Miwa; Toshiyuki Sasaguri; Kiyoyoshi Nishita; Masaru Tanokura; Iwao Ohtsuki
Journal:  Biochem Biophys Res Commun       Date:  2005-11-02       Impact factor: 3.575

4.  Molecular Dynamics and Umbrella Sampling Simulations Elucidate Differences in Troponin C Isoform and Mutant Hydrophobic Patch Exposure.

Authors:  Jacob D Bowman; Steffen Lindert
Journal:  J Phys Chem B       Date:  2018-08-02       Impact factor: 2.991

Review 5.  Myofilament dysfunction in cardiac disease from mice to men.

Authors:  Nazha Hamdani; Monique de Waard; Andrew E Messer; Nicky M Boontje; Viola Kooij; Sabine van Dijk; Amanda Versteilen; Regis Lamberts; Daphne Merkus; Cris Dos Remedios; Dirk J Duncker; Attila Borbely; Zoltan Papp; Walter Paulus; Ger J M Stienen; Steven B Marston; Jolanda van der Velden
Journal:  J Muscle Res Cell Motil       Date:  2009-01-13       Impact factor: 2.698

6.  Increased Ca2+ affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I.

Authors:  Tomoyoshi Kobayashi; R John Solaro
Journal:  J Biol Chem       Date:  2006-03-10       Impact factor: 5.157

7.  Effects of Cardiac Troponin I Mutation P83S on Contractile Properties and the Modulation by PKA-Mediated Phosphorylation.

Authors:  Yuanhua Cheng; Steffen Lindert; Lucas Oxenford; An-Yue Tu; Andrew D McCulloch; Michael Regnier
Journal:  J Phys Chem B       Date:  2016-05-18       Impact factor: 2.991

8.  Disease-related cardiac troponins alter thin filament Ca2+ association and dissociation rates.

Authors:  Bin Liu; Svetlana B Tikunova; Kristopher P Kline; Jalal K Siddiqui; Jonathan P Davis
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

9.  Molecular Effects of cTnC DCM Mutations on Calcium Sensitivity and Myofilament Activation-An Integrated Multiscale Modeling Study.

Authors:  Sukriti Dewan; Kimberly J McCabe; Michael Regnier; Andrew D McCulloch; Steffen Lindert
Journal:  J Phys Chem B       Date:  2016-05-06       Impact factor: 2.991

10.  Inherited cardiomyopathies caused by troponin mutations.

Authors:  Qun-Wei Lu; Xiao-Yan Wu; Sachio Morimoto
Journal:  J Geriatr Cardiol       Date:  2013-03       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.